By 2015, 160 billion USD of drug patents will expire, and global consumption of drugs will reach 1,1 trillion USD, with 60 to 70 % market share of generics.
Chinese specialists expect that this will provide excellent opportunities for Chinese enterprises focused on generics, e. g., on generic therapeutic antibodies.

China Bio news release, December 18, 2013